{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+Propionate%2FSalmeterol+DISKUS+250%2F50mcg", "query": { "intervention": "Fluticasone Propionate/Salmeterol DISKUS 250/50mcg" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 15, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Fluticasone+Propionate%2FSalmeterol+DISKUS+250%2F50mcg&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-10-05T08:30:25.963Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00355342", "title": "Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Salmeterol 50 mcg BID", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol 250/50 mcg BID", "type": "DRUG" }, { "name": "DISKUS inhaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 186, "start_date": "2004-04-28", "completion_date": "2007-09-06", "has_results": true, "last_update_posted_date": "2018-07-02", "last_synced_at": "2026-10-05T08:30:25.963Z", "location_count": 37, "location_summary": "Berkeley, California • Fullerton, California • Rancho Mirage, California + 31 more", "locations": [ { "city": "Berkeley", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Rancho Mirage", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Walnut Creek", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00355342" }, { "nct_id": "NCT00115492", "title": "Advair® DISKUS® Versus Serevent® DISKUS® For Chronic Obstructive Pulmonary Disease Exacerbations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone Propionate/Salmeterol Combination Product", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 797, "start_date": "2004-12", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2017-01-20", "last_synced_at": "2026-10-05T08:30:25.963Z", "location_count": 95, "location_summary": "Jasper, Alabama • Mobile, Alabama • Glendale, Arizona + 88 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Berkeley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00115492" }, { "nct_id": "NCT01324362", "title": "GSK BHR Study (Sont - Second Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "FP 100mcg", "type": "DRUG" }, { "name": "FP 250mcg", "type": "DRUG" }, { "name": "FP 500mcg", "type": "DRUG" }, { "name": "FSC 100/50mcg", "type": "DRUG" }, { "name": "FSC 250/50mcg", "type": "DRUG" }, { "name": "FSC500/50mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 446, "start_date": "2003-01", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2016-09-01", "last_synced_at": "2026-10-05T08:30:25.963Z", "location_count": 51, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Glendale, Arizona + 43 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01324362" }, { "nct_id": "NCT00920543", "title": "GSK BHR Study (Sont)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "FP 100mcg", "type": "DRUG" }, { "name": "FP 500mcg", "type": "DRUG" }, { "name": "FP 250mcg", "type": "DRUG" }, { "name": "FSC 100/50mcg", "type": "DRUG" }, { "name": "FSC 250/50mcg", "type": "DRUG" }, { "name": "FSC 500/50mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 464, "start_date": "2003-02", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2016-09-01", "last_synced_at": "2026-10-05T08:30:25.963Z", "location_count": 52, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 45 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Carmichael", "state": "California" }, { "city": "Palmdale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00920543" }, { "nct_id": "NCT00784550", "title": "A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Tiotropium Bromide", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "40 Years to 99 Years" }, "enrollment_count": 342, "start_date": "2008-12", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2016-11-23", "last_synced_at": "2026-10-05T08:30:25.963Z", "location_count": 35, "location_summary": "Riverside, California • Fort Collins, Colorado • Clearwater, Florida + 31 more", "locations": [ { "city": "Riverside", "state": "California" }, { "city": "Fort Collins", "state": "Colorado" }, { "city": "Clearwater", "state": "Florida" }, { "city": "DeLand", "state": "Florida" }, { "city": "Naranja", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00784550" }, { "nct_id": "NCT01225913", "title": "Mechanism(s) of Airflow Limitation During Exacerbation of Asthma", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "fluticasone/salmeterol in all asthmatics", "type": "DRUG" }, { "name": "budesonide/formoterol or fluticasone/salmeterol in all asthmatics", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gelb, Arthur F., M.D.", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "10 Years to 80 Years" }, "enrollment_count": 50, "start_date": "2007-10", "completion_date": "2027-06", "has_results": false, "last_update_posted_date": "2023-10-26", "last_synced_at": "2026-10-05T08:30:25.963Z", "location_count": 1, "location_summary": "Lakewood, California", "locations": [ { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01225913" }, { "nct_id": "NCT00984659", "title": "Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone propionate/salmeterol combination product", "type": "DRUG" }, { "name": "Salmeterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 366, "start_date": "2009-10-29", "completion_date": "2010-07-01", "has_results": true, "last_update_posted_date": "2018-08-29", "last_synced_at": "2026-10-05T08:30:25.963Z", "location_count": 39, "location_summary": "Jasper, Alabama • Mobile, Alabama • Los Angeles, California + 35 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00984659" }, { "nct_id": "NCT00857766", "title": "A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "ADVAIR DISKUS™ 250/50mcg", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 249, "start_date": "2009-03", "completion_date": "2010-03", "has_results": true, "last_update_posted_date": "2017-01-30", "last_synced_at": "2026-10-05T08:30:25.963Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Mobile, Alabama + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00857766" }, { "nct_id": "NCT00452699", "title": "A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone Propionate/salmeterol xinofoate 250/50 mcg BID", "type": "DRUG" }, { "name": "Fluticasone propionate 250 mcg BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 621, "start_date": "2007-05", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2016-12-08", "last_synced_at": "2026-10-05T08:30:25.963Z", "location_count": 58, "location_summary": "Scottsdale, Arizona • Little Rock, Arkansas • Fountain Valley, California + 48 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Rancho Mirage", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00452699" }, { "nct_id": "NCT00633217", "title": "Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone Propionate/Salmeterol DISKUS 250/50mcg", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a MDI 230/42mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 247, "start_date": "2008-03", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2016-12-08", "last_synced_at": "2026-10-05T08:30:25.963Z", "location_count": 16, "location_summary": "Jasper, Alabama • Mobile, Alabama • Lafayette, Louisiana + 13 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Lafayette", "state": "Louisiana" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Sunset", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00633217" } ] }